Wyeth Enters Manufacturing Agreement for Genentech's Herceptin
This article was originally published in The Pink Sheet Daily
Executive Summary
Bulk drug substance for Herceptin will be manufactured at Wyeth's Andover, Mass. facility. The companies should be familiar with this type of arrangement since Genentech signed a deal in 2002 to manufacture Wyeth/Amgen's Enbrel.